Product Information

LOTEPREDNOL ETABONATE 0.5% DRP is a generic product labeled by Padagis US LLC, priced at $9.8751 per ML under NDC 00574413505. Its NADAC has been published 42 times since Feb 4, 2026.

FDA first approved this application on Jan 29, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOTEPREDNOL ETABONATE 0.5% DRP

loteprednol etabonate
$9.8751per ML

Strength

5 mg/mL

Manufacturer

Padagis US LLC

NDC

00574413505

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

LOTEPREDNOL ETABONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215204

FDA Approved

1/29/2025

TE Code

AB

On Market Since

12/15/2025

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has been published 42 times since Feb 4, 2026, and over the history we have for it it has declined 43.4%. The table below summarizes its recorded NADAC range and movement.

Current price$9.8751 per ML
All-time high$17.4624 (Feb 11, 2026)
All-time low$9.8751 (Nov 18, 2026)
52-week high$17.4624
52-week low$9.8751
Median price$10.5316
Average price$11.4276
Largest weekly change-19.6% (Feb 18, 2026)
Weeks tracked42
Tracking sinceFeb 4, 2026

Price History

1W

-5.4%

1M

-5.7%

3M

-6.2%

6M

-8.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

-43.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOTEPREDNOL ETABONATE 0.5% DRP?

The current National Average Drug Acquisition Cost (NADAC) for LOTEPREDNOL ETABONATE 0.5% DRP, manufactured by Padagis US LLC, is $9.8751 per ML (NDC 00574413505), effective Nov 18, 2026.

How has the price of LOTEPREDNOL ETABONATE 0.5% DRP changed over time?

Over the history we have for it, the NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has declined 43.4%. It has been tracked across 42 weekly CMS publications since Feb 4, 2026.

What are the highest and lowest recorded NADAC prices for LOTEPREDNOL ETABONATE 0.5% DRP?

Since Feb 4, 2026, the NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has ranged from a low of $9.8751 (Nov 18, 2026) to a high of $17.4624 (Feb 11, 2026), with a median of $10.5316 per ML.

Are there cheaper alternatives to LOTEPREDNOL ETABONATE 0.5% DRP?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOTEPREDNOL ETABONATE 0.5% DRP in a comparable dosage form, but none are currently priced below it.

Who manufactures LOTEPREDNOL ETABONATE 0.5% DRP?

LOTEPREDNOL ETABONATE 0.5% DRP (NDC 00574413505) is labeled by Padagis US LLC, and CMS classifies it as a generic product.